AgelessRx vs Effecty
Two GLP-1 desks, one scoreboard. We put AgelessRx and Effecty head-to-head on the published Brief Score — the same six factors, scored the same way.
Effecty
The verdict
Effecty takes this head-to-head.
Effecty scores 86 to 85 on our six-factor Brief Score — One of the few accredited desks pairing compounded pricing with brand-name access, nationwide.
That doesn't make AgelessRx a bad call — it's best for budget-focused readers who want a low semaglutide sticker and a longevity-medicine framing. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| AgelessRx | Effecty | |
|---|---|---|
| Brief Score | 85/100 (B) | 86/100 (B) |
| Semaglutide | $139/mo | $160/mo |
| Tirzepatide | Not disclosed | $240/mo |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
AgelessRx: Low tracked semaglutide sticker; tirzepatide price still undisclosed.
Effecty: $160 sema / $240 tirz; LegitScript-certified with brand-name access nationwide.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.